Cliff Asness's HUMA Position Overview
Cliff Asness (via Aqr Capital Management LLC) currently holds 1.92 M shares of Humacyte, Inc. (HUMA) worth $1.17 M, representing 0.00% of the portfolio. First purchased in 2022-Q1, this medium-term investment has been held for 13 quarters.
Based on 13F filings, Cliff Asness has maintained a strategic position in HUMA, demonstrating sustained confidence in this investment. Largest addition occurred in Q1 2026, adding 1.89 M shares. Largest reduction occurred in Q3 2025, reducing 376,609 shares.
Analysis based on 13F filings available since 2013 Q2
Cliff Asness's Humacyte (HUMA) Holding Value Over Time
Track share changes against reported price movement
Quarterly Humacyte (HUMA) Trades by Cliff Asness
| Report Date | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q1 2026 | +1.89 M | Add 5590.31% | 1.92 M | $0.61 |
| Q4 2025 | -224,242 | Reduce 86.89% | 33,824 | $0.96 |
| Q3 2025 | -376,609 | Reduce 59.34% | 258,066 | $1.74 |
| Q2 2025 | +620,118 | Add 4259.93% | 634,675 | $2.09 |
| Q1 2025 | -37,545 | Reduce 72.06% | 14,557 | $1.71 |
| Q4 2024 | -14,921 | Reduce 22.26% | 52,102 | $5.05 |
| Q3 2024 | -189,319 | Reduce 73.85% | 67,023 | $5.44 |
| Q2 2024 | +233,422 | Add 1018.42% | 256,342 | $4.80 |
| Q1 2024 | -20,417 | Reduce 47.11% | 22,920 | $3.11 |
| Q4 2023 | +43,337 | New Buy | 43,337 | $2.84 |
| Q3 2022 | -18,366 | Sold Out | 0 | $0.00 |
| Q2 2022 | -1,913 | Reduce 9.43% | 18,366 | $3.21 |
| Q1 2022 | +20,279 | New Buy | 20,279 | $7.05 |
Cliff Asness's Humacyte Investment FAQs
Cliff Asness first purchased Humacyte, Inc. (HUMA) in Q1 2022, acquiring 20,279 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Cliff Asness has held Humacyte, Inc. (HUMA) for 13 quarters since Q1 2022.
Cliff Asness's largest addition to Humacyte, Inc. (HUMA) was in Q1 2026, adding 1,924,691 shares worth $1.17 M.
According to the latest 13F filing for Q1 2026, Cliff Asness's firm, Aqr Capital Management LLC, owns 1,924,691 shares of Humacyte, Inc. (HUMA), valued at approximately $1.17 M.
As of the Q1 2026 filing, Humacyte, Inc. (HUMA) represents approximately 0.00% of Cliff Asness's publicly disclosed stock portfolio, making it one of their key holdings.
Cliff Asness's peak holding in Humacyte, Inc. (HUMA) was 1,924,691 shares, as reported at the end of Q1 2026.